3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Glioma
3
Glioblastoma
3
Astrocytoma
2
Whooping Cough
1
Sarcoma
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pneumococcal Infections
1
Oligodendroglioma
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Medulloblastoma
1
Measles
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hodgkin Disease
1
Hepatitis B
1
HIV Infections
1
Gliosarcoma
1
Carcinoma
1
Advanced Cancer
1
Interventions
fludarabine phosphate
58
Cyclophosphamide
54
Peripheral Blood Stem Cell Transplantation
49
Mycophenolic Acid
39
Busulfan
38
Tacrolimus
37
Cyclosporine
33
Antilymphocyte Serum
33
Whole-Body Irradiation
32
Filgrastim
28
Methotrexate
27
Radiotherapy
20
Melphalan
18
Cytarabine
17
fludarabine
16
Etoposide
16
Methylprednisolone
14
ruxolitinib
11
sargramostim
9
Flow Cytometry
9
Cyclosporins
9
Cord Blood Stem Cell Transplantation
9
Alemtuzumab
9
thymoglobulin
8
Sirolimus
8
Psychiatric Rehabilitation
8
Granulocyte Colony-Stimulating Factor
8
Azacitidine
8
merphos
7
Decitabine
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Myeloproliferative Disorders
×
Tetanus Toxoid
×
Clear all
NCT01611298
2020-04-21
TAR
Baylor College of Medicine
Phase NA
Completed
7 enrolled
8 charts